1. Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer. Issue 5 (22nd December 2019) Authors: Mayadev, Jyoti; Zamarin, Dmitriy; Deng, Wei; Lankes, Heather; O'Cearbhaill, Roisin; Aghajanian, Carol A; Schilder, Russell Journal: International journal of gynecological cancer Issue: Volume 30:Issue 5(2020) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TP011/#1527 GOG 3039 a phase II study of abemaciclib in combination with letrozole in advanced, recurrent or metastatic endometrioid endometrial cancer. (4th December 2022) Authors: Huang, Marilyn; Huang, Gloria; Sill, Michael; Lewin, Sharon; Gill, Sarah; Lankes, Heather; Coleman, Robert L; Slomovitz, Brian Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗